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Abstract

Integrated care models for substance use disorder (SUD) and reproductive health care
have been proposed as a strategy to increase access to reproductive health care for women in
treatment for SUD. This cross-sectional, survey-based study measured how women of
childbearing age in residential treatment report their demand for and access to reproductive
health care, their pregnancy intention, contraceptive utilization and preference for integrating
reproductive health care with their current SUD treatment milieu. Eighty-five percent of the
women interviewed (N=108) expressed a desire to prevent pregnancy in the next year, although
only one-third (33.6%) were using a form of contraception at the time of the study. The majority
of women (69%) reported their preference for the integration of contraceptive care and treatment
for SUD. If cost was not an issue, 28.7% of women would prefer a long acting reversible
contraceptive (LARC) and 40.7% would prefer either injectables, oral contraceptive pills or
patches. Improving access to reproductive health for women in treatment for SUD by integrating
these services may increase uptake of all methods of contraception and would be well received
by most women. Eliciting the preferences of women related to family planning and pregnancy
prevention and then responding to those preferences with affordable or no cost access to
contraception is a public health imperative. These practice changes stand to improve the myriad
health outcomes for women and children associated with unintended pregnancy in the context of
SUD.
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Introduction and Background
Substance use disorder (SUD) is defined in the Diagnostic and Statistical Manual of
Mental Disorders, 4th edition, as a “maladaptive pattern of substance use leading to clinically
significant impairment or distress” (American Psychiatric Association, 2013). According to the
Substance Abuse and Mental Health Services Administration (2020), 7.2 million women aged 18
and older had SUD in 2018. Since 2005, substance use disorders are being listed among the top
ten major public health concerns in the United States population (Albright & Rayburn, 2009;
Thacker et al., 2005).
In 2011, nearly half of the 6.1 million pregnancies in the United States were unplanned.
However, this is the lowest rate since at least 1981 (Guttmacher Institute, 2019). This drop in the
rate of unintended pregnancy in the general population is likely due to an overall increase in the
use of highly effective contraceptive methods (Guttmacher Institute, 2019). Women with active
SUD have significantly greater odds of an unintended pregnancy compared to women who do
not have an active SUD (Terplan, Hand, Hutchinson, Salisbury-Afshar, & Heil, 2015; Than et
al., 2005) due to the inconsistent use of reliable contraceptives (Drescher-Burke, 2014; Sharma,
Aggarwal, & Dubey, 2002; Terplan et al., 2015). An estimated 90% of women with active SUD
report a history of at least one unintended pregnancy (Heil et al., 2011). Rates of unintended
pregnancy for all women correlate to inconsistent use of effective contraception, but women with
SUD are particularly vulnerable because they often lack access to reproductive healthcare both
when they are active in their addiction, when they enter treatment and when they are discharged
from treatment (Bornstein, Gipson, Bleck, Sridhar, & Berger, 2018; Drescher-Burke, 2014;
Robinowitz, Muqueeth, Scheibler, Salisbury-Afshar, & Terplan, 2016; Terplan et al., 2015).
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Women with SUD who become pregnant face many social and emotional hardships
during pregnancy such as fear of criminalization, feelings of guilt and shame, and stigmatization
from both health care professionals and society at large (Metz, Köchl, & Fischer, 2012). These
hardships can lead to initial or exacerbation of psychiatric conditions such as post-traumatic
stress disorder, depression or anxiety, which often underlie women’s substance abuse. In 2018,
4.4 million women over the age of 18 had co-occurring SUD and mental illness (Substance
Abuse and Mental Health Services Administration, 2020). Furthermore, unintended pregnancy is
a risk for relapse among women in recovery for active SUD (ASAM, 2017; Metz et al., 2012).
Stressors during pregnancy can cause relapse in women with SUD or an increased use of
substances for women with untreated SUD (Metz et al., 2012). When a woman in recovery for
active SUD relapses, the risk for morbidity and mortality increases significantly (Metz et al,
2012).
Despite the increasing number of SUD treatment facilities, only 11% (2.64 million) of the
24 million men and women with SUD receive treatment (Saia et al., 2016). Of the 2.64 million
men and women that receive treatment for SUD, only 23% are women (Center for Behavioral
Health Statistics and Quality, 2014). The peak age of women receiving treatment for SUD and
peak fertility age overlap (Center for Behavioral Health Statistics and Quality, 2014). In addition
to known barriers to treatment such as insurance coverage, treatment readiness, and inability to
afford treatment, women report unique barriers to SUD treatment that are related to motherhood
including limited child-care availability, increased social stigma and fear of criminal or child
welfare consequences (Chen, Strain, Crum, & Mojtabai, 2013; Saia et al., 2016). Furthermore,
many treatment facilities do not accept pregnant women with active SUD, which increases risk
for overdose in the women and poses a risk for the fetus as well.
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Women enrolled in SUD treatment programs identified numerous barriers to reproductive
health services, including not being asked about family planning, unable to fill prescriptions for
birth control, difficulty making and getting to appointments, and not knowing they could discuss
reproductive health services while in a treatment facility for substance use (Robinowitz et al.,
2016). For many women, SUD treatment facilities are the only source of medical care at the time
of enrollment (Substance Abuse and Mental Health Services Administration, 2017). A
systematic review by Terplan et al. (2015) concluded that offering contraception services in
conjunction with SUD treatment could help reduce unintended pregnancy in this population.
However, a review of literature returned only one study to date reflecting the preferences of
women in treatment for SUD for the integration of contraception services with their current
treatment milieu. In 2016, Terplan, Lawental, Connah, and Martin measured women’s preference
for accessing family planning services at treatment sites including residential, intensive
outpatient, outpatient and medication assisted treatment (MAT). This study, which conducted
focus groups and in-depth interviews with 115 women and 95 men about their family planning
needs, knowledge of reproductive health and preferences for integration, found that 83% of
women and 58% of men would be more likely to use reproductive health services if they were
offered through their SUD treatment program.
Problem Statement
The benefit of women-specific SUD treatment programs include a safe environment to
address reproductive health needs such as contraception and family planning. Several studies
address low contraception adherence among women with SUD, however do not explore the
preferences of women related to seeking care and reproductive intention in the context of
recovery (Griffith, Kumaraswami, Chrysanthopoulou, Mattocks, & Clark, 2017; Robinowitz et
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al., 2016). Existing evidence suggests that co-locating SUD treatment and reproductive health
services can benefit women by eliminating known barriers to access and increasing reproductive
autonomy, thereby preventing unplanned pregnancies (Robinowitz et al., 2016; Terplan et al.,
2016).
Purpose
The purpose of this study is to evaluate access to reproductive healthcare including
contraception for women enrolled in treatment for SUD as well as their preferences for
integration of family planning into treatment for SUD. Actively seeking the preferences of this
currently underserved population will help identify and leverage opportunities for health
promotion. Actively seeking and responding to this population’s preferences represents a move
to support women’s reproductive autonomy while improving their access to evidence-based
contraceptive counselling and the full range of contraceptive methods.
Review of Evidence
The prevalence of substance use disorder (SUD) in the United States is high. One in 10
people have SUD (Substance Abuse and Mental Health Services Administration, 2017);
approximately one-third of whom are women (Griffith et al., 2017). The National Institute of
Drug Abuse (2018) has identified the importance of gender in the course and treatment of SUD
and the particular risk for morbidity and mortality experienced by women with untreated SUD.
The peak age of women with SUD and peak fertility age overlap, making reliable contraception
essential for this population. The rate of unintended or unplanned pregnancy in women with
SUD is much higher than women without SUD (Drescher-Burke, 2014; Heil et al., 2011,
Robinowitz et al., 2016, Smith, Morse, & Busby, 2019; Terplan et al., 2015).
Lack of Access to Reproductive Care
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There are several reasons identified in the literature for why women with SUD have
lower consistent use of reliable contraceptive methods, however poor access to reproductive care
is frequently cited as a barrier to the consistent use of effective contraception (Black & Day,
2016; Black, Stephens, Haber, & Lintzeris, 2012; Drescher-Burke, 2014; Griffith et al., 2017;
Meschke, McNeely, Brown, & Prather, 2018; Robinowitz et al., 2016; Terplan et al., 2016).
Provider bias has also been recognized as a barrier; when women with SUD attempt to access
contraceptive services, providers tend to prioritize treatment for substance use as well as
screening and treatment for sexually transmitted diseases (Drescher-Burke, 2014; Griffith et al.,
2017; Terplan et al., 2015). However, authors have also found that women who were screened
and/or treated for sexually transmitted infections were also more likely to receive contraceptive
counseling and to then elect a method of birth control (Robinowitz et al., 2016; Terplan et al.,
2016). A study by Smith, Morse and Busby (2019) found that while women in treatment for
opioid use disorder were clear about their intention to avoid pregnancy, they also reported low
rates of consistent birth control use, election of accessible but less effective methods of
pregnancy prevention, alongside limited access to primary care and gynecologic services.
Insurance plays a vital role in access. As previously stated, women self-report lack of
insurance coverage as a barrier to SUD treatment. Most women are eligible for Medicaid once
they become pregnant and remain insured 60 days postpartum. As of 2017, 11% of women in
America remain uninsured (approximately 10.6 million women) and 17% receive insurance from
Medicaid (Kaiser Family Foundation, 2018). Those who are uninsured, active in their SUD
without access to SUD treatment or reproductive health services are at the highest risk for poor
health outcomes. Unfortunately, 25 states have limited scope Medicaid programs, which limits
funds towards family planning services (Kaiser Family Foundation, 2018). From 2009 to 2012,
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48 percent of women entering substance use treatment facilities who were not pregnant were
uninsured (Smith & Lipari, 2017). Women who are insured and/or are able to access SUD
treatment may still lack access to reproductive health care. A focus group revealed that women
with SUD consistently describe challenges in accessing contraception and family planning
services, even while in treatment (Robinowitz et al., 2016).
Patient-Centered Treatment
Before the 1970s, substance use treatment facilities followed a generic approach, with
little recognition of the specific treatment needs of women (Greenfield & Grella, 2009). Many
national institutions such as the Substance Abuse and Mental Health Services Administration
(SAMHSA) and National Institute on Drug Abuse (NIDA) now recognize the need for womencentered programming as a cornerstone of effective SUD treatment and recovery. Womencentered programs focus on the treatment of SUD along with women-specific care and
counseling for issues related to family counseling, behavioral health and reproductive health
services (Krans et al., 2018; Robinowitz et al., 2016). Unique challenges that women face when
enrolling into a treatment program include limited child-care availability, increased social stigma
and fear of criminal or child welfare consequences (Chen et al., 2013; Saia et al., 2016).
Treatment centers specific to women and their needs were established to try to increase retention
rates for women in inpatient treatment programs (Arfken, Klein, di Menza, & Schuster, 2001).
Integration of Reproductive Care
Integration of reproductive health services with SUD treatment may help decrease the
challenges women with SUD face in accessing contraception and increase contraceptive
utilization. A study that interviewed 115 women in SUD treatment facilities found that women
are more proactive about family planning and planning their futures while in treatment
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(Robinowitz et al., 2016). MacAfee, Harfmann, Kolenic and Dalton (2017) found that women
preferred integration of reproductive services with their SUD treatment. Improving access to
comprehensive care and access to the full range of contraceptive options increases the use of
reliable methods (Institute of Medicine, 2004).
Importance of Contraception
Consistent use of effective contraception decreases rates of unintended pregnancy
(Guttmacher Institute, 2019). An unintended pregnancy can trigger preexisting psychological
conditions such as anxiety and depression for women (Biaggi, Conroy, Pawlby, & Pariante,
2016). Women are often at higher risk for relapse and overdose during prenatal and postpartum
time because stress is a known trigger for relapse (American Society of Addiction Medicine,
2017). Women who relapse are also at higher risk for overdose and death. Improving access to
evidence-based contraceptive counseling and the full range of contraceptive methods increases
reproductive autonomy by supporting women to choose how and whether to plan or prevent
pregnancy (Upadhyay, Dworkin, Weitz, & Foster, 2014).
Along with personal benefits to the woman, contraception use can also delay pregnancy
until the woman is sober and free of substances. The effects of substance exposure on neonates
are widely known (Bornstein et al., 2018). Prenatal substance use can increase the risk of preterm
delivery, abruptio placenta, fetal growth restriction, intrauterine fetal demise, and neonatal
abstinence syndrome (NAS) compared with infants who were not exposed to substances
(Bornstein et al., 2018; Stanhope, Gill, & Rose, 2013). In 2012, medical bills for all infants
treated for NAS totaled $1.5 billion (Ko et al., 2017). Unintended pregnancies in women with
SUD is associated with inadequate care, low birth weight and prematurity (Logan, Holcombe,
Manlove, & Ryan, 2007). The number of women with opioid use disorder at labor and delivery
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quadrupled from 1999 to 2014 (Haight, Ko, Tong, Bohm, & Callaghan, 2018). In order to
decrease adverse outcomes and the incidence of high-risk pregnancies, the World Health
Organization encourages contraceptive counseling and access to contraception for women with
SUD (World Health Organization, 2014).
Integrating reproductive health care services into patient-centered SUD treatment models
for women can alleviate reproductive health care disparities among women with SUD that result
in myriad poor health outcomes for both women and children. Evidence-based contraceptive
counseling empowers women with information and choice which improves health seeking
behavior and increases reproductive autonomy by emphasizing each woman’s choice to decide if
and when she would like to have a child.
Theoretical Model
The Social Cognitive Theory (SCT) is a health behavior theory that describes a dynamic,
ongoing process in which personal factors, environmental factors, and human behavior exert
influence upon each other (Bandura, 1986). SCT integrates concepts from cognitive, behaviorist,
and emotional models of behavior change, but is centered around the assumption of reciprocal
determinism. This means that a person can be both an agent for change and a responder to
change (Glanz, Burke, & Rimer, 2018). The three main constructs of SCT are personal factors,
environmental factors or behavior. Within each of the three main constructs there are a number
of concepts that help illuminate the construct and help organize variables such as behavioral
capability, expectations, self-efficacy, observational learning (modeling), and reinforcements
(National Institutes of Health, 2005). Behavioral capability is the knowledge and skill needed to
perform a given behavior. Expectations are anticipated outcomes of behavior. Self-efficacy is the
confidence in one’s ability to take action and overcome barriers.
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The Social Cognitive Theory is used as a theoretical framework through which to
understand the factors predicting uptake of reproductive health care services among women in
treatment for substance use disorder (SUD). Personal factors that influence reproductive health
in women with SUD are reproductive intention, contraceptive preference, and preference for
integration of contraception into SUD treatment. Environmental factors include access to health
care and engagement in SUD treatment. Human behavior can be measured by past and current
contraceptive utilization. The three constructs, personal factors, environmental factors and
behavior, are continually interacting and influencing one another, a dynamic known as reciprocal
determinism (Bandura, 1986). Personal factors are influenced by environmental factors. For
example, cost, convenience, and access are environmental factors that influence personal factors
such as preference of contraception, or preference to integrate contraception into SUD treatment.
This project is examining all the factors of the SCT that influence one another continuously. See
figure 1.
Project Design
This cross-sectional survey-based study was designed to measure how women engaged in
residential treatment report their demand for and access to reproductive health care, their
pregnancy intention, contraceptive utilization and preference for integrating reproductive health
care with their current SUD treatment milieu. This project was approved by the Belmont
Institutional Review Board in October 2019
Clinical Setting
The study was conducted at a women’s residential SUD treatment facility in Nashville,
Tennessee. The facility is a non-profit, faith-based organization that treats women from the
Southeastern United States for addiction to alcohol, opioids, and other illicit drugs. Inpatient
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services for medical detox are available as needed. After detox, women begin the recommended
30-day residential treatment program, which includes medication assisted treatment (MAT), drug
and alcohol withdrawal management, behavioral health, life skills, and peer led recovery
meetings such as alcoholics anonymous (AA) and narcotics anonymous (NA).
The recommended residential treatment program is 30 days and women are eligible to
participate in treatment if they are 18 years or older, speak English, and have Medicaid or private
health insurance. Women who are uninsured may apply for scholarship funding available
through grants. Most commercial and government-funded insurances cover 30 days of residential
treatment. Women who receive a grant are approved for 30 days of residential treatment as well.
Women are eligible for treatment regardless of their current pregnancy status. The facility has a
total of 38 client rooms along with six detox beds. At capacity, the facility can provide
residential treatment for 76 women. While engaged in care, women live together in a community
and receive services as smaller groups of 10-12 women.
Project Population
Women aged 18 to 51 years who were admitted and receiving treatment at the facility
between October and December 2019 were eligible to participate in the study. Women over the
age of 51 or those who had been in-house for less than 48 hours were not eligible to participate.
The age of 51 years was selected because it is the average age of menopause and reproductive
services are still essential up to that age (Terplan et al., 2016). Women must have been in-house
for at least 48 hours as this is the average amount of time needed to regain cognition after
ingestion of any substance (Terplan et al., 2016).
Convenience sampling was used to recruit eligible participants. Flyers describing the
study were posted throughout the facility and the project leader made announcements during
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weekly medical group meetings, describing the study and inviting women to complete the
interview-led survey. Participation was voluntary and participant responses were kept
confidential. No personally identifying information was collected by the project leader.
Sources of Data/Data Collection Instruments
The survey used for this study was created by the project leader using questions from
multiple other survey instruments to measure demographics, access to health care, specifically
reproductive health care, reproductive intent, contraception utilization and preference for
integration of reproductive health services with SUD treatment. See Appendix for adapted survey
with standardized script.
Section I of the survey captured age in number, ethnicity, highest level of education and
marital status. These demographic questions were adapted from the Centers for Disease Control
(2018) National Survey of Family Growth.
Section II of the survey measured access to health care. Because the survey was
completed using Qualtrics survey software, some skip logic was used in this section. A question
about health insurance status was asked using a “yes/no” response. If the participant selected yes,
the next question asked about the type of health insurance. However, if the participant selected
no, using skip logic, the question about type of health insurance was omitted. Type of health
insurance was measured using a multiple-choice question. Another question asked where specific
services, such as well-women exam, STD screening, and prescription or method for birth control
were received in the past. Multiple choice options were provided to determine where specific
services were received. These questions were adapted from a study measuring the trends in
contraceptive services of young women in America (Frost & Lindberg, 2019). A final question in
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this section asked participants where they would go for care if they were sick. Multiple choice
options are presented. This question was adapted from the Guttmacher Institute (2009).
Section III of the survey measured contraceptive utilization. The first question in this
section asked whether certain contraceptive methods had been used in the past year. Responses
were “yes/no”. The next question asked whether the participant was currently on a form of birth
control. If the participant answered yes, the next question would ask what type of birth control
they were on; however, if the participant answered no, using skip logic that question was
omitted. A “yes/no” question asked whether cost had been a barrier in obtaining the preferred
choice of birth control in the past. The next multiple choice question asked how the participant
has paid for birth control in the past year. These questions were adapted from a survey from
Guttmacher Institute (2009) which surveyed young adults about contraception utilization. The
remaining questions in this section used skip logic. A “yes/no” question about condom use in the
past six months was asked. If the participant answered no to using condoms in the past 6 months,
the section would end. However, if the participant selected yes, further questions were asked.
Further questions included primary purpose for using condoms with options of “STD
prevention”, “pregnancy prevention”, or “both”. The next question asked about frequency of
condom use with multiple choice responses of “Always”, “most of the time”, or “sometimes”.
These questions were adapted from a survey which asked about intention to have sexual
intercourse without a condom (Duran, Ferraces, Rodriguez, Rio & Sabucedo, 2017).
Section IV of the survey measured reproductive intent. One multiple choice question was
adapted to measure desire to become pregnant in the next year. The question was adapted from
“Improving Contraception Uptake Baseline Questionnaire” (Black & Day, 2016). Using skip
logic, pregnancy intention was not asked to those who had indicated a previous tubal ligation or
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hysterectomy. Section V of the survey measured preference for integration. Questions for this
section were adapted from Bich, Korthuis, Thu, Dinh and Minh (2016). The original study
measured the preference for integrating SUD treatment into existing HIV treatment plans.
Although the variables are different for this study, the logic of integration translates well. Skip
logic was used for these questions. The section begins with a “yes/no” question asking whether
the participant would feel comfortable speaking about contraception at the facility where the
study took place. If the participant answered yes, the next question would ask which provider
they would feel most comfortable talking to (doctors, nurse practitioners, pharmacists, nurses,
therapists, or case managers). If the participant answered no, this question was omitted. The next
question asked whether the participant would be interested in receiving birth control upon
discharge from the facility. If the participant answered either yes or not sure, the next question
would ask them which method of contraception they would be interested in, which is a multiple
choice question. If the participant answered no, the survey ends. The question about which
method of contraception they would be interested in was added to the survey by the request of
the facility and stakeholders.
The adapted survey was reviewed for content validity by the project advisor and a Doctor
of Nursing Practice nurse practitioner who works with a similar population as the study
population. Because the survey was adapted from various other surveys and is intended to
provide descriptive statistics, it cannot be deemed valid or reliable. The survey was piloted with
six non-medical clinical associates at the facility who are in recovery for SUD and completed
residential treatment either at the facility or at a similar inpatient facility.
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Data Collection Process/Procedures
The project leader used a standardized script to guide participants through the survey and
input survey responses into a laptop computer using Qualtrics survey software. To eliminate
barriers to participation related to response fatigue, literacy and health literacy in this population,
the project leader read the questions aloud for each participant using the standardized script. The
survey took approximately seven minutes to complete. The surveys were completed one at a time
in a private room at the facility. Participation was voluntary, and no protected health information
was collected. A letter of invitation with implied consent was presented to participants. The letter
clearly stated that participation in the study does not promise access to any services. In order to
thank participants for their time, a candy bar was given at the end of the survey. A resource
packet with local health departments and information about different contraception options was
offered to all participants.
Data Analysis
Data was collected using Qualtrics survey software. Collected data was then entered into
SPSS software for analysis. Analysis included descriptive statistics to explore demographics,
health care access, contraception utilization, reproductive intent and preference for integration.
Results
From the months of October 2019 to December 2019, there were 219 admissions into the
residential program. A total of 108 women completed the survey (N=108). The response rate was
49%. The median age of participants was 32 years. Three-fourths (74%) were Caucasian, and
nearly half had completed a high school diploma or earned a GED (46.3%). Over half (54.6%) of
the sample were single, never married. Participants’ demographic characteristics are summarized
in Table 1.
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Access to Care
Three-fourths (74.1%) of the sample had health insurance at the time of the survey. Of
the 80 that had health insurance, 93% were covered by Medicaid or a type of governmentassistance plan. In response to the item “when you are sick, where do you go for care?”, 36
(33.3%) women indicated care from a primary care provider (PCP), 38 (35.1%) women reported
care from an urgent care or walk-in clinic, and 34 (31.6%) women reported having visited
Emergency Department. For reproductive healthcare, a majority of women (63%) reported
having visited a private doctor’s office for a well woman exam; and about half (48.1%) reported
receiving STD screenings at a community or public health clinic such as the health department.
However, half of the women (53.7%) reported having received a prescription or method of birth
control from a private doctor’s office, compared to 36.1% that received this from a community
or public health clinic. Figures 2, 3, 4, and 5 depict women’s access to health care and all data
related to access to care are summarized in Table 2.
Reproductive Intent and Contraception Utilization
Twenty women (18.5%) reported having had a tubal ligation or a hysterectomy and so
were not asked about their reproductive intent. Of the remaining women (n=88), the majority
(85.2%) reported not wanting to become pregnant in the next year, 6 (6.8%) wanted to become
pregnant in the next year, 1 (1.1%) was not sure, and 6 (6.8%) reported being “okay” either way.
All data related to reproductive intent may be found in Table 3.
Participants’ responses about utilization of contraceptive methods were categorized based
on efficacy and likelihood of becoming pregnant using research adapted by the Centers of
Disease Control (2018). Tier 1 includes the implant, and an intrauterine device (IUD). Tier 1
methods are considered to be the most effective contraceptive method with less than one
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pregnancy per 100 women in one year (Trussell, Aiken, Micks, & Guthrie, 2018). Of the women
who had not had a hysterectomy or tubal ligation (n=88), 16 (18.2%) women reported having
used tier one methods in the past year. When asked about current use, 14 (15.9%) reported using
tier 1 methods. Tier 2 includes oral contraceptives, patches, vaginal ring, and injectables. Tier 2
methods are moderately effective with four to seven pregnancies per 100 women in one year
(Trussell et al., 2018). Of the women who had not had a hysterectomy or tubal ligation (n=88),
27 (30.6%) women reported having used tier 2 methods in the past year. When asked about
current use, 11 (12.5%) women reported use of tier 2 methods. Tier 3 includes withdrawal
method, rhythm method, emergency contraception and condoms. Tier 3 methods are the least
effective methods with more than 13 pregnancies per 100 women in one year (Trussell et al.,
2018). Of the women who had not had a hysterectomy or tubal ligation (n=88), 65 (73.8%)
women reported having used tier 3 contraceptive methods in the past year. The vast majority of
women (71.6%) of women reported that they were not using any form of contraception at the
time of the survey. Tables 4a and 4b provide a full report of contraceptive utilization in the past
year and utilization at the time of the survey.
One-fourth (25.9%) of the participants reported cost as a barrier to obtaining the birth
control of their choice. When asked how they paid for their birth control in the last year, 42
(38.8%, N=108) women reported Medicaid insurance coverage, and 57 (52.7%, N=108) reported
they had not used birth control in the past year. About half of the women (n=52) reported using
condoms in the past six months. When asked frequency of condom use, 12 (23%) reported
always using condoms, 24 (46.2%) reported using condoms most of the time, and 16 (30.7%)
reported using condoms sometimes. Of the 52 women who reported condom use in the past six
months, 18 (34.6%) reported using condoms for STD prevention, five (9.6%) reported using
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condoms for pregnancy prevention, and 29 (55.7%) reported using them for both STD
prevention and pregnancy prevention. Table 5a and 5b summarizes how women reported paying
for their birth control and their condom utilization.
Preference for Integration
In response to the question “If we could provide you with a method of birth control of
your choice before you leave, would you be interested?”, the majority (69.4%) said yes, and
98.1% of women stated they would feel comfortable talking about birth control while in
treatment for substance use disorder. When asked who they would feel most comfortable talking
to about birth control, 54 (50%) stated nurses, 25 (23.1%) stated therapists, 25 (23.1%) stated
nurse practitioners or doctors, and 4 (3.7%) stated case managers. All data related to preference
for integration is summarized in Table 6.
Discussion
Although 85% of participants reported a desire to avoid pregnancy in the next year, only
one-third (33.6%) were using any form of contraception at the time of the survey. Although the
rate of effective contraceptive use was low, preference for integration of contraception with SUD
treatment was high. The majority of women responded with a preference to integrate access to
contraception with their treatment for SUD and almost 70% reported that they would choose to
initiate contraception prior to discharge from treatment if it were made available and cost were
no obstacle. Of the women who were interested in integration of services, 14.8% indicated
preference for an IUD, 13.9% indicated preference for an implant, 16.7% indicated preference
for oral contraception, 22.2% indicated preference for injectables and 1.8% indicated preference
for the patch. This finding suggests that while the preference for integration of services was
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almost unanimous, women express preference for a variety of methods, but their responses
suggest that removing cost as a barrier would drive the election of more effective methods.
While half of the women were most comfortable speaking about contraception to nurses
at their SUD facility, the other half were most comfortable with either a therapist, case manager
or nurse practitioner. This suggests the importance of trust and relationship in the discussion of
family planning and that there is variability around whom a woman may feel most comfortable.
This echoes literature that supports all staff training in contraceptive counseling as an important
aspect of improving access; hence, it is vital that all disciplines are trained in contraceptive
counseling. By educating and training all disciplines in a SUD treatment facility, women have an
equal opportunity to approach a conversation about contraception with whoever they are most
comfortable with.
Previous studies suggest that women with SUD have a decreased uptake of contraception
due to lack of access to health care, specifically reproductive health care. This study found that
only 63% of women had ever received a well-women exam at a private doctor’s office and only
53% had ever received a prescription or method of birth control from a private doctor’s office.
This supports existing literature on the disparities in access to reproductive healthcare
documented in this vulnerable population which is also evidenced by their use of urgent care or
emergency departments for care when they are sick (66%). This suggests that women with SUD
might not receive continuous and consistent care from a provider who is aware of their
reproductive health history and SUD diagnosis.
Compared to previous studies, this study found a higher uptake of long-acting reversible
contraception (LARC) in this sample compared to women in previous studies. Previous studies
published rates of LARC uptake among women with SUD as under 6% (Smith et al., 2019;
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Terplan et al., 2016). However, this study shows a 13% uptake of LARCs. This percentage lags
behind the LARC uptake in the general population at 15% but is encouraging (National Survey
of Family Growth, 2017). The finding that 68.4% of women reported using less reliable methods
of contraception such as withdrawal method, rhythm method, emergency contraception and
condoms may also be experiencing cost as a barrier to more reliable methods, along with access
to a provider, availability and education. The results show that 14 (12.9%) women came into
treatment with an existing LARC and 31 (28.7%) reported preference for a LARC in the absence
of cost as a barrier. This suggests that women who came into treatment with a LARC report a
preference to continue using LARCs to prevent pregnancy. This finding may be leveraged as an
asset in the group treatment milieu because peer influence can be a powerful tool in decision
making when it comes to contraception selection (Smith, Morse, & Busby, 2019).
Of the 48% of women who reported using condoms in the past six months, only 23% of
those reported always using condoms. Of the women who reported using condoms, 55.7%
reported using them for pregnancy prevention and STD prevention. Not only are women
reporting high rates of using an ineffective method to prevent pregnancy but are also using this
ineffective method inconsistently. If women were offered the method of contraception they
preferred, the health outcomes for women and children associated with unintended pregnancy
could improve.
These findings add to the existing literature that supports integration of contraception into
SUD treatment. Similar to previous findings, this study found that women do indeed prefer the
integration of contraception into SUD treatment. These results show us that a majority of women
enter treatment without any method of contraception, and if these services are not offered during
treatment, the likelihood of women receiving contraception elsewhere once discharged is
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unlikely. Known barriers to reproductive health care will continue to decrease contraceptive
utilization in this population. To support and promote reproductive autonomy and women’s right
to decide whether and how to prevent or plan future pregnancies, treatment facilities should elicit
and respond carefully to the preferences of women before any intervention is implemented.
Because the survey was conducted at a facility where a majority of the women have some
form of insurance, the responses about cost as a barrier to accessing contraception might be
different compared to women who do not have insurance. In this study, 25.9% of women
reported cost as a barrier to receiving a method of contraception of their choice. Interestingly,
25.9% of women did not have insurance at the time of the survey. This study did not ask about
sexual orientation, number of sexual partners, or knowledge of contraceptives; in previous
literature these variables have been of interest. The participating 108 women constituted 49% of
the population at one inpatient treatment facility in Nashville, Tennessee during the span of two
months. As such, the preferences and experiences expressed by these women may not be an
accurate representation of the population across the state, let alone the population across the
country. However, the study sample does demographically represent the larger population of
women in Tennessee who are currently accessing treatment for SUD and thus serves as a
valuable source of information about the value of eliciting patient preferences as first step toward
improving access to reproductive health for this population.
Conclusion
Women in SUD treatment have unmet reproductive health needs. Of the approximately
one-third of women who reported current use of contraception, 13% entered treatment with a
LARC. However, 85% did not want to become pregnant in the next year. Women in this study
voiced a strong preference for integrated contraception and SUD treatment, but a minority of
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women preferred separate care for SUD treatment and contraception. Integrating contraception
with SUD treatment has shown to increase rates of effective contraceptive use, however the
preferences of women should be considered before implementing any interventions. Future
research should explore whether women prefer contraceptive counseling as a group or
individually. This study highlights the importance of eliciting patient preference for service
integration as well as responding to the expressed preferences of women by improving access to
all methods of contraception.
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Figure 2. Locations utilized for treatment of illness among women in inpatient treatment for
substance use disorder in Nashville, TN (N=108).
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Figure 3. Locations utilized for Well Woman Exams among women in inpatient treatment for
substance use disorder in Nashville, TN (N=108).

NEEDS AMONG WOMEN WITH SUD

1%

1%

34

STD Screening

3%

Private Doctor's Office
Community/Public Health
Clinic
47%

Planned Parenthood

48%

Urgen care/Hospital
Never Received This

Figure 4. Locations utilized for STD screenings among women in inpatient treatment for
substance use disorder in Nashville, TN (N=108).
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Figure 5. Locations utilized for obtaining a prescription or method for birth control among
women in inpatient treatment for substance use disorder in Nashville, TN (N=108).
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Tables

Table 1. Sample demographics of women in inpatient treatment for substance use disorder in
Nashville, TN (N=108).
Characteristic
Age (years)
19-29
30-40
41-51
Ethnicity
African American/Black
Hispanic/Latino
Caucasian/White
Native American/American Indian
Asian/Pacific Islander
Mixed Race
Education
Some High School
High School or GED
Some College
2-year college degree
4-year college degree
Graduate or professional degree
Marital Status
Single, never married
Married
Divorced or annulled
Separated, not divorced
Insurance (Y/N)
Yes
No
Insurance Type
Employer
Purchased Directly/Private
Medicaid/Government-assistance plan

n (%)
37 (34.3)
59 (54.6)
12 (11.1)
18 (16.7)
2 (1.9)
80 (74.1)
3 (2.8)
1 (0.9)
4 (3.7)
21 (19.4)
50 (46.3)
18 (16.7)
12 (11.1)
6 (5.6)
1 (0.9)
59 (54.6)
17 (15.7)
18 (16.7)
14 (13)
80 (74.1)
28 (25.9)
2 (1.9)
4 (3.7)
74 (68.5)

Table 2. Access to health care providers and preferred locations for treatment of illnesses among
women in inpatient treatment for substance use disorder in Nashville, TN (N=108).
Access to Care
Sick Care
Primary Care Provider
Urgent Care/Walk-In
Emergency Department

n (%)
36 (33.3)
38 (35.1)
34 (31.6)
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Well Woman Exam
Private Doctor’s Office
Community/Public Health Clinic
Planned Parenthood Clinic
Urgent Care/Hospital
Never received this service
STD Screening
Private Doctor’s Office
Community/Public Health Clinic
Planned Parenthood Clinic
Urgent Care/Hospital
Never received this service
Prescription/Method of Birth Control
Private Doctor’s Office
Community/Public Health Clinic
Planned Parenthood Clinic
Urgent Care/Hospital
Never received this service

68 (63)
32 (29.6)
4 (3.7)
1 (0.9)
3 (2.8)
51 (47.2)
52 (48.1)
3 (2.8)
1 (0.9)
1 (0.9)
58 (53.7)
39 (36.1)
3 (2.8)
0
8 (7.4)

Table 3. Reproductive intent for the next year among women in inpatient treatment for substance
use disorder in Nashville, TN (n=88). This question was not asked to 20 women who indicated
tubal ligation or hysterectomy.
Reproductive Intent
Would like to become pregnant
Do not want to become pregnant
Not sure
Okay either way

n (%)
6 (6.8)
75 (85.2)
1 (1.1)
6 (6.8)

Table 4a. Contraception utilization within the past year among women in inpatient treatment for
substance use disorder in Nashville, TN (N=108).
Methods of Contraception
Oral Contraceptives
Condoms
Injectables
Patch
Intrauterine Devices (IUD)
Implant
Vaginal Ring
Rhythm Method
Emergency Contraception
Withdrawal Method
Tubal Ligation/Hysterectomy

Yes [n (%)]
12 (11.1)
56 (51.9)
13 (12)
1 (0.9)
9 (8.3)
7 (6.5)
1 (0.9)
3 (2.8)
6 (5.6)
23 (21.3)
20 (18.5)

No [n (%)]
96 (88.9)
52 (48.1)
95 (88)
107 (99.1)
99 (91.7)
101 (93.5)
107 (99.1)
105 (97.2)
102 (94.4)
85 (78.7)
88 (81.5)
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Table 4b. Contraception utilization at the time of the survey among women in inpatient
treatment for substance use disorder in Nashville, TN (n=88). This is a sub-sample after
removing women with hysterectomies and tubal ligations.
Contraception Utilization
Current Contraception Use
Yes
No
Method
Tier 1
IUD
Implant
Tier 2
Oral contraceptives
Injectables

n (%)
25 (28.4%)
63 (71.6%)

7 (7.9%)
7 (7.9%)
6 (6.8%)
5 (5.6%)

Table 5a. Payment methods for contraception in the past year (N=108).
Payment Method
Private Insurance
Medicaid or government-assistance plan
Out-of-pocket payment
No payment necessary
Not applicable (Haven’t received birth
control in past year)

n (%)
3 (2.8)
42 (38.9)
1 (0.9)
5 (4.6)
57 (52.8)

Table 5b. Condom utilization in the past six months.
Condom Utilization
Yes
No
*Primary Purpose for use
STD Prevention
Pregnancy Prevention
Both
*Frequency of Use
Always
Most of the time
Sometimes
*Percentages reported as a sub-sample of 52 women who answered yes to using condoms.

n (%)
52 (48.1)
56 (51.9)
18 (34.6)
5 (9.6)
29 (55.7)
12 (23)
24 (46.2)
16 (30.7)
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Table 6. Preference for integration of birth control with substance use disorder treatment
programs.
Preferences for Integration
Most Comfortable Talking About Birth
Control With
Nurse Practitioners/Doctors
Nurses
Therapists
Case Managers
Interest in Receiving Birth Control Before
Discharge
Yes
No
Not Sure
Choice of Contraception if Provided Before
Discharge
Tier 1
IUD
Implant
Tier 2
Oral Contraception
Injectables
Patch
None (I do not want any form)

n (%)

25 (23.1)
54 (50)
25 (23.1)
4 (3.7)

75 (69.4)
30 (27.8)
3 (2.8)

16 (14.8)
15 (13.9)
18 (16.7)
24 (22.2)
2 (1.8)
33 (30.5)
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Appendix

Adapted survey
Thank you so much for agreeing to participate in this women’s health and birth control survey. I
really appreciate your time. Over the next few minutes I will be asking you some questions about
to your personal health, the health care you receive, and some specific questions about birth
control. When I say birth control I am referring to any way you would prevent pregnancy
including pulling out, condoms, the pill, the shot, the patch, IUDs, implants. You do not have to
answer the questions you don’t want to. Please stop me at any time if you have questions about
what I say. I am happy to answer any questions and repeat any information. Everything we say
during this session is confidential, including all of your answers and any personal information.
At the end of this survey you will receive a candy bar and a resource packet. Are you ready to
get started?
I’d like to start off by asking you a few general questions about yourself.
Section I: Demographics
1. How old are you? (enter age in whole numbers) __________________
2. Please specify your ethnicity:
a. African American or Black
b. Hispanic or Latino
c. White
d. Native American or American Indian
e. Asian/Pacific Islander
f. Other: _____________________
3. What is the highest level of education you have completed?
a. Some high school
b. High school diploma
c. Some college credit, but did not graduate college
d. 2-year college degree
e. 4-year college degree
f. Graduate or professional school
4. What is your marital status?
a. Single, never married
b. Married
c. Divorced or annulled
d. Separated, not divorced
e. Widowed
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The next few questions will be about health care.
Section II: Access to Care
5. Do you currently have health insurance?
a. Yes
b. No
6. What type of health insurance do you have?
a. Insurance through a current or former employer or union
b. Insurance purchased directly from an insurance company
c. Medicaid, Medical Assistance, or any kind of government-assistance plan for those
with low incomes or disabilities
d. TRICARE or other military health care
e. VA
7. If you are sick, where do you go for care?
a. My primary care provider
b. Retail health clinic/walk-in clinic
c. Urgent Care
d. Emergency Department
e. Other: _______________
I am going to list off specific services that you may have received. Let me know where you
received these services such as doctor’s office, planned parenthood, hospital/urgent care, etc. If
you have not received a service, simply state “I have not received that service before”.
8. For the following questions, please mark where you received each service.
a. Well-women exam
i. Private doctor's office/HMO
ii. Community or Public health clinic
iii. Family planning/Planned Parenthood clinic
iv. Urgent care/hospital
v. Never received these types of services
b. STD screening
i. Private doctor's office/HMO
ii. Community or Public health clinic
iii. Family planning/Planned Parenthood clinic
iv. Urgent care/hospital
v. Never received these types of services
c. Prescription for birth control or a method of birth control
i. Private doctor's office/HMO
ii. Community or Public health clinic
iii. Family planning/Planned Parenthood clinic
iv. Urgent care/hospital
v. Never received these types of services
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Section III: Contraception Utilization
I am going to show you a chart of different types of birth control methods. Please point at which
methods you have used in the PAST YEAR- you can point at more than one method if you have
used multiple methods in the past year.
9. Have you used any of the following methods in the past year? (select yes or no)
a. Birth control pills or oral contraceptives (“the pill”)
yes
no
b. Male condoms
yes
no
c. Injectable birth control
yes
no
d. Birth control patch (Ortho-Eva)
yes
no
e. Intrauterine devices/IUD
yes
no
f. Birth control implants
yes
no
g. Vaginal ring (Nuva-ring)
yes
no
h. Diaphragm, sponge, female condom, foam, cream
yes
no
i. Rhythm method/natural family planning
yes
no
j. Sterilization (tubal ligation or hysterectomy)
yes
no
k. Emergency contraception or “morning after pill”
yes
no
l. Withdrawal or “pulling out” method
yes
no
10. Are you currently using any form of birth control?
a. Yes
b. No
11. Specify which type of birth control you are currently on?
a. Birth control pills
b. Injectables (Depo-Provera)
c. Implant (Nexplanon/Implanon)
d. IUD
e. Vaginal ring
f. Patch
g. Tubal ligation (I’ve had my tubes “tied”)
h. Condoms
Sometimes, different methods of birth control have different costs associated with them.
12. Has cost ever been a barrier in obtaining the birth control of your choice?
a. Private insurance
b. Medicaid or other public insurance (TennCare)
c. Out-of-pocket payment
d. No payment necessary or copayment only
e. Not applicable (Haven’t received birth control in the past year)
13. Have you used a condom in the past 6 months?
a. Yes
b. No
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14. What is your primary purpose for using condoms?
a. STD prevention
b. Pregnancy prevention
c. Both
15. How frequently do you use condoms?
a. Always
b. Most of the time
c. Sometimes
Section IV: Reproductive Intent
16. Would you like to become pregnant in the next year?
a. Yes
b. No
c. Not sure
d. Okay either way
Section V: Preference for Integration
17. Would you feel comfortable talking about birth control at The Next Door?
a. Yes
b. No
18. Who would you feel most comfortable talking to?
a. Doctors
b. Nurse Practitioners
c. Pharmacists
d. Nurses
e. Therapists
f. Case Managers
19. If we could provide you with a method of birth control of your choice before you leave,
would you be interested?
a. Yes
b. No
c. Not sure
20. If birth control were available at this location, and cost was not an issue, which method
would you choose to use?
a. Oral birth control pills
b. IUS/IUS (intrauterine device)
c. Depo-Provera shot
d. Implant (Nexplanon)
e. None, I do not want any form of birth control
f. Other: ________________
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Women’s Health Survey
 Are you a woman between 18 and 51 years of age?
 Are you interested in voicing your thoughts on birth control and
women’s health?
 Do you want to be a part of a helpful research study?

If you answered YES to any of these questions, you may be eligible to
participate in an interview about birth control and family planning.

The interview will take less than 10 minutes. To thank you for your time,
you will receive a candy bar at the conclusion of the interview. No
medications will be given.
Where: Consult Room 2-2 (2nd floor)

